# Arrowhead Pharmaceuticals, Inc.: Form 8-K, filed Aug 8, 2024

- Company: [Arrowhead Pharmaceuticals, Inc.](/companies/arwr.md) (CIK 879407)
- Form: 8-K
- Filed: 2024-08-08
- Accepted by EDGAR: Aug 8, 2024, 16:04 ET
- Period: 2024-08-08
- Accession: 0001628280-24-036113
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/879407/000162828024036113/arwr-20240808.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/879407/000162828024036113/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/879407/000162828024036113/arwr-20240808.htm

Filed Aug 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-036113. Last ingested by Listed: Nov 4, 2026, 07:39 ET. No prices; not investment advice.